NIH-funded research R01 grant

Early heart changes linked to worsening kidney function in type 1 diabetes

Official title: Early myocardial remodeling and progressive kidney function decline in type 1 diabetes

Funded at Joslin Diabetes Center · NIH-11232350 · Data updated 2026-11-12

This project will look at whether people with type 1 diabetes who are losing kidney function have early changes in heart muscle compared with people with stable kidney function and people without diabetes.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJoslin Diabetes Center
NIH-funded
Lab location1 site (Boston, United States)
Project startDecember 24, 2021
Project endNovember 30, 2026
Funding year2026
Award (this year)$828,756
NIH project number5R01HL161858-05
Project IDNIH-11232350 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with type 1 diabetes and early chronic kidney disease (CKD stage 1–3A), especially those with documented GFR loss ≥3 ml/min/year over the past 3–6 years, as well as age-matched people without diabetes for the control group.

Less likely to help

People with advanced kidney failure (CKD stage 4–5 or on dialysis), those with only type 2 diabetes, or anyone unable to undergo MRI are unlikely to be included or directly benefit from this project.

What this research studies

We will invite three groups of people: 100 with type 1 diabetes who have lost kidney function recently (GFR decliners), 100 with type 1 diabetes and stable kidney function, and 100 people without diabetes of similar age. Participants will get advanced cardiac MRI to measure heart muscle cell size and function, along with blood and urine biomarker tests and routine clinical exams. The team will compare imaging and biomarker results across the groups to find early signs of diabetic cardiomyopathy tied to kidney decline. Visits and imaging take place at the Joslin Diabetes Center and focus on adults with early-stage CKD (stage 1–3A).

Why it matters

Potential benefit: If successful, this work could help detect heart muscle changes earlier in people with type 1 diabetes who are losing kidney function and guide ways to prevent heart failure.

How similar studies have gone: Early work from this team and others has shown MRI markers can detect subtle heart muscle changes in diabetes, but this focused comparison by recent GFR loss is relatively new.

Where this research is happening

  • Joslin Diabetes Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Doria, Alessandro — Joslin Diabetes Center
  • Study coordinator: Doria, Alessandro

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.